Regencell Bioscience Holdings Ltd. RGC
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Regencell Bioscience Holdings Ltd. is a bioscience company specializing in the research, development, and commercialization of Traditional Chinese Medicine (TCM) formulations. It targets neurocognitive disorders and degenerations, with a primary focus on Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectr…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryHong Kong
Employees10
TickerRGC
Statistics
Market Cap$7.36B
Revenue (TTM)—
Net Income-$3.6M
Net Margin—
EPS$-0.72
P/E-2725.00
P/S—
P/B10155.00
EV/EBITDA-1421.08
ROE-177.7%
Dividend Yield—
Price$14.88
Data: Twelve Data · Revenue = mcap / P/S